MNG
AZN icon

Manning & Napier Group’s AstraZeneca AZN Stock Holding History

Manning & Napier Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$190M Buy
1,405,535
+15,929
+1% +$2.11M 2.17% 10
2023
Q4 		$187M Buy
1,389,606
+1,025,032
+281% +$133M 2.22% 11
2023
Q3 		$49.4M Buy
364,574
+2,091
+0.6% +$286K 0.61% 48
2023
Q2 		$51.9M Buy
+362,483
New +$53.3M 0.59% 50

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Manning & Napier Group's AZN Position: Q1 2024 in Review

Manning & Napier Group increased its AstraZeneca (AZN) stake by 1.1% in Q1 2024, buying an estimated $2.11M and bringing the position to 1,405,535 shares worth $190M. The position accounts for 2.17% of the portfolio, ranked #10.

Manning & Napier Group first reported a position in AZN in Q2 2023 and has held it in 4 quarters since. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Manning & Napier Group held 1,405,535 shares of AstraZeneca worth $190M as of Q1 2024.
  • Manning & Napier Group bought 15,929 AstraZeneca shares in Q1 2024, an estimated $2.11M.
  • AstraZeneca made up 2.17% of Manning & Napier Group's portfolio in Q1 2024, its #10 holding.
  • Manning & Napier Group first reported a position in AstraZeneca in Q2 2023 and has held it in 4 quarters since.
  • 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Manning & Napier Group's 13F filing for Q1 2024, filed 15 Apr 2024.